Melanocortin receptor ligands

Ligands des recepteurs de la melanocortine

Melanocortinrezeptorliganden

Abstract

The present invention is directed to a compound according to the formula:          Ac-Arg-c(Cys-D-Ala-His-D-Phe-Arg-Trp-Cys)-NH 2 and pharmaceutically-acceptable salts thereof. This compound acts as a ligand for one or more of the melanocortin receptors. The invention also relates to methods of using this compound to treat mammals and to pharmaceutical compositions comprising said compound.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (13)

    Publication numberPublication dateAssigneeTitle
    US-5595760-AJanuary 21, 1997DelabSustained release of peptides from pharmaceutical compositions
    US-5672659-ASeptember 30, 1997Kinerton LimitedIonic molecular conjugates of biodegradable polyesters and bioactive polypeptides
    US-5821221-AOctober 13, 1998Biomeasure, IncorporatedIonic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
    US-5916883-AJune 29, 1999Poly-Med, Inc.Acylated cyclodextrin derivatives
    US-6350430-B1February 26, 2002Lion Bioscience Science AgMelanocortin receptor ligands and methods of using same
    US-6525019-B2February 25, 2003The Children's Medical Center CorporationUse of melanin for inhibition of angiogenesis and macular degeneration
    US-6600015-B2July 29, 2003Hoffmann-La Roche Inc.Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
    US-6613874-B1September 02, 2003The Procter & Gamble CompanyMelanocortin receptor ligands
    US-6639123-B1October 28, 2003Merck & Co., Inc.Melanocortin-3 receptor deficient cells, non-human trangenic animals and methods of selecting compounds which regulate body weight
    US-6713487-B2March 30, 2004Bristol-Myers Squibb Co.Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
    US-6720324-B2April 13, 2004Synaptic Pharmaceutical CorporationSelective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
    WO-2005000339-A2January 06, 2005Eli Lilly And CompanyMelanocortin receptor 4(mc4) agonists and their uses
    WO-2005060985-A1July 07, 2005Merck & Co., Inc., The University Of North Carolina At Chapel HillInhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists

NO-Patent Citations (69)

    Title
    ANDERSSON, K-E. ET AL., INT. J. IMPOTENCE RES., vol. 14, 2002, pages S82 - S92
    BASTIENS, M. T. ET AL., AM. J. HUM. GENET., vol. 68, 2001, pages 884 - 894
    BEDNAREK, M. A. ET AL., EXPERT OPINION THER. PATENT, vol. 14, 2004, pages 327 - 336
    BERTOLINI, A. ET AL., J. ENDOCRINOL. INVEST., vol. 4, 1981, pages 241 - 251
    BOHM, M. ET AL., J. INVEST. DERMATOL., vol. 118, 2002, pages 533 - 539
    CATANIA, A. ET AL., PHARM. REV., vol. 56, 2004, pages 1 - 29
    CHAKI, S. ET AL., PEPTIDES, vol. 26, 2005, pages 1952 - 1964
    CHHAJLANI, V. ET AL., FEBS LETT., vol. 309, 1992, pages 417 - 420
    CONE ET AL., ANN. N.Y. ACAD. SCI., vol. 31, 1993, pages 342 - 363
    CONE ET AL., RECENT PROG. HORM. RES., vol. 51, 1996, pages 287 - 317
    CONE, R. D. ET AL., ANN. N.Y. ACAD. SCI., vol. 680, 1993, pages 342 - 363
    CONE, R. D. ET AL., RECENT PROG. HORM. RES., vol. 51, 1996, pages 287 - 318
    DE WIED, D. ET AL., METHODS ACHIEV. EXP. PATHOL., vol. 15, 1991, pages 167 - 199
    DE WIED, D. ET AL., PHYSIOL. REV., vol. 62, 1982, pages 977 - 1059
    DIAMOND, L. E. ET AL., UROLOGY, vol. 65, 2005, pages 755 - 759
    DUMONT, L. M. ET AL., PEPTIDES, vol. 26, 2005, pages 1929 - 1935
    ELLERKMANN, E. ET AL., ENDOCRINOL., vol. 130, 1992, pages 133 - 138
    FAROOQI, 1. S. ET AL., NE J MED., vol. 348, 2003, pages 1085 - 1095
    FAROOQI, I. S. ET AL., NE J MED., vol. 348, 2003, pages 1085 - 1095
    FEHM, H. L. ET AL., J. CLIN. ENDO. & METAB., vol. 86, 2001, pages 1144 - 1148
    FOURCROY, J. L., DRUGS, vol. 63, 2003, pages 1445 - 1457
    GANTZ, 1. ET AL., J. BIOL. CHEM., vol. 268, 1993, pages 15174 - 15179
    GANTZ, I. ET AL., J. BIOL. CHEM., vol. 268, 1993, pages 8246 - 8250
    GE, Y. ET AL., BRAIN RESEARCH, vol. 957, 2002, pages 42 - 45
    GETTING, S. J. ET AL., CURR. OPIN. INVESTIG. DRUGS, vol. 2, 2001, pages 1064 - 1069
    GIRAUDO, S. Q. ET AL., BRAIN RES., vol. 809, 1998, pages 302 - 306
    GUBER, K.A. ET AL., AM. J. PHYSIOL., vol. 257, 1989, pages R681 - R694
    GURA, T., SCIENCE, vol. 287, 2000, pages 1738 - 1740
    HAMILTON, B. S. ET AL., OBESITY RES., vol. 10, 2002, pages 182 - 187
    HANSEN, M. J. ET AL., BRAIN RES., vol. 1039, 2005, pages 137 - 145
    HARRIS, R. B. ET AL., PHYSIOL. BEHAV., vol. 73, 2001, pages 599 - 608
    HASKELL-LUEVANO C ET AL: "BIOLOGICAL AND CONFORMATIONAL EXAMINATION OF STEREOCHEMICAL MODIFICATIONS USING THE TEMPLATE MELANOTROPIN PEPTIDE, AC-NLE-CÄASP-HIS-PHE-ARG-TRP-ALA-LYSÜ-NH2, ON HUMAN MELANOCORTIN RECEPTORS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, vol. 40, no. 11, 1 January 1997 (1997-01-01), pages 1738 - 1748, XP002159224, ISSN: 0022-2623
    HATTA, N. ET AL., J. INVEST. DERMATOL., vol. 116, 2001, pages 564 - 570
    HOPPS, C. V. ET AL., BJU INTERNATIONAL, vol. 92, 2003, pages 534 - 538
    KASK, A. ET AL., NEUROREPORT, vol. 10, 1999, pages 707 - 711
    LECHAN, R. M. ET AL., ENDO, vol. 142, 2001, pages 3288 - 3291
    LUGER, T. A. ET AL., PATHOBIOLOGY, vol. 67, 1999, pages 318 - 321
    LUSCOMBE, C. J. ET AL., BRITISH J. CANCER, vol. 85, 2001, pages 1504 - 1509
    MACNEIL, D. J. ET AL., EU. J. PHARM., vol. 44, 2002, pages 141 - 157
    MACNEIL, D. J. ET AL., EU. J. PHARM., vol. 450, 2002, pages 93 - 109
    MARKISON, S. ET AL., ENDOCRINOLOGY, vol. 146, 2005, pages 2766 - 2773
    MARSILJE, T. H. ET AL., BIOORG. MED. CHEM. LETT., vol. 14, 2004, pages 3721 - 3725
    MIONI, C. ET AL., EU. J. PHARM., vol. 477, 2003, pages 227 - 234
    MOLINOFF, P. B. ET AL., ANN. N.Y. ACAD. SCI., vol. 994, 2003, pages 96 - 102
    MOUNTJOY, K. G. ET AL., SCIENCE, vol. 257, 1992, pages 1248 - 1251
    MURPHY, M. T. ET AL., SCIENCE, vol. 221, 1983, pages 192 - 193
    NAVARRO, M. ET AL., ALCOHOL CLIN. EXP. RES., vol. 29, 2005, pages 949 - 957
    PONTILLO, J. ET AL., BIOORGANIC & MED. CHEM. LTRS., vol. 15, 2005, pages 2541 - 2546
    RAFFIN-SANSON, M. L., EU. J. ENDO., vol. 144, 2001, pages 207 - 208
    ROSEN, R. C. ET AL., INT. J. IMPOTENCE RES., vol. 16, 2004, pages 135 - 142
    SCHNOLZER ET AL., INT. J. PEPTIDE PROTEIN RES., vol. 40, 1992, pages 180
    SCHWARTZ, M. W., J. CLIN. INVEST., vol. 108, 2001, pages 963 - 964
    SHADIACK, A. M. ET AL., SOCIETY FOR NEUROSCIENCE ABSTRACT, 2003
    SHARMA H. S. ET AL., ACTA. NEROCHIR., vol. 86, 2003, pages 399 - 405
    SHARMA H.S., ANN. N.Y. ACAD. SCI., vol. 1053, 2005, pages 407 - 421
    STURM, R.A., MELANOMA RES., vol. 12, 2002, pages 405 - 416
    TATRO, J. B. ET AL., ENDOCRINOL., vol. 121, 1987, pages 1900 - 1907
    VAN DER PLOEG, L. H. T. ET AL., PNAS, vol. 99, 2002, pages 11381 - 11386
    VERSTEEG, D. H. G. ET AL., LIFE SCI., vol. 38, 1986, pages 835 - 840
    VOISEY, J. ET AL., CURR. DRUG TARGETS, vol. 4, 2003, pages 586 - 597
    VRINTEN, D. ET AL., J. NEUROSCIENCE, vol. 20, 2000, pages 8131 - 8137
    WALKER J.M. ET AL., SCIENCE, vol. 210, 1980, pages 1247 - 1249
    WESSELLS, H. ET AL., INT. J. IMPOTENCE RES., vol. 12, 2000, pages S74 - S79
    WESSELLS, H. ET AL., J. UROLOGY, vol. 160, 1998, pages 389 - 393
    WESSELLS, H. ET AL., NEUROSCIENCE, vol. 118, 2003, pages 755 - 762
    WESSELLS, H. ET AL., PEPTIDES, vol. 26, 2005, pages 1972 - 1977
    WESSELLS, H. ET AL., UROLOGY, vol. 56, 2000, pages 641 - 646
    WISSE, B. R. ET AL., ENDO, vol. 142, 2001, pages 3292 - 3301
    YE, Z. ET AL., PEPTIDES, vol. 26, 2005, pages 2017 - 2025

Cited By (0)

    Publication numberPublication dateAssigneeTitle